Term
|
Definition
|
|
Term
|
Definition
increase in cell size; cells of heart and kidneys particularly responsive to enlargement; increase in cellular size is associated with an increased accumulation of protein in the cellular components (plasma membrane, ER, myofilaments, mitochondria); can be physiologic or pathologic & is caused by specific hormone stimulation or increased functional demand |
|
|
Term
|
Definition
|
|
Term
|
Definition
reversible replacement of one mature cell type by another less mature cell type |
|
|
Term
|
Definition
deranged cellular growth (not considered a true cellular adaption but rather an atypical hyperplasia) |
|
|
Term
Mechanisms of Hypertrophy |
|
Definition
- hormonal stimulation (uterus in pregnancy)
- ↑ functional demand (exercise, myocardial failure, ↑ cardiac workload)
- ↑ cell size from cellular protein accumulation, not fluid (heart, kidneys)
- physiologic hypertrophy reversible
- triggers: mechanical (stretch) and trophic (growth factor and vasoactive agents) signals
|
|
|
Term
Mechanisms of Hyperplasia
|
|
Definition
- loss of epithelial cells → ↑ rate of cell division
- physiologic: compensatory (liver regeneration) and hormonal (↑ estrogen & mam glands during preg) [note: nerves, skeletal muscle, myocardial cells, & optical lenses DO NOT regenerate]
- pathologic: endometrial hyperplasia or neoplasms
- may occur with hypertrophy (except in such non-dividing cells as myocardial fibers)
|
|
|
Term
|
Definition
- reprogramming of stem cells (epithelia) or undifferentiated mesenchymal cells (connective tissue)
- different cell maturation pathway signaled by cytokines and growth factors
- bronchial: smoking (reversible v. neoplasm)
-ciliated, columnar epithelial cells replaced with stratified squamous epithelial cells
|
|
|
Term
Common Biochemical Derangements of Cell Injury & Death |
|
Definition
- ↓ ATP: cellular swelling, ↓ protein synthesis, ↓ membrane transport, lipogenesis
- ROS: destroy cell membranes and structure
- inactivate enzymes, damage cell membrane, injure nucleic acids (DNA)
- ↑ Ca in cell: intracellular damage from enzyme activation
- membrane permeability defects: ↓ protein, co-enzymes, RNA, and ATP substrates
|
|
|
Term
|
Definition
|
|
Term
Cellular Injury Mechanisms: Chemical |
|
Definition
- toxin- cell membrane interaction
-direct toxicity -free radicals, lipid peroxidation -cellular responses -lipid accumulation -membrane defects → cellular swelling - ↓ ATP, Ca++ influx into mitochondira (↓oxidative metabolism) - DNA degradation - Lysosomal membrane injury→enzyme leak into cytoplasm→digestion of all cell organelles→DNA synthesis halted -air pollutants, insecticides, social drugs, etc.
- Lead toxicity
-heavy metal, lungs and GI absorption -↑ intracellular Ca++→ neurotransmitter interference (alters fetal & pediatric neurodevelopment, learning disorders, hyperactivity, attention deficit, convulsions) -↓ enzymes for Hgb synthesis & RBC lysis (hemolysis)→anemia -renal deposits→tubular dysfunction (glycosuria, proteinuria, hyperphosphaturia) -lead based paint/toys, glazed pottery, print shop, plumbing, engine repair
- CO poisoning:
-odorless, colorless gas -incomplete combustion of fuel -interferes with cellular respiration -affinity for Hgb 300X > than O2 -binds to Hgb (carboxyhemoglobin)-prevents O2 binding→hypoxia (HA, giddiness, tinnitus, N/V) -↑fetal risk
|
|
|
Term
Cellular Injury Mech: Hypoxia |
|
Definition
- ischemia/anoxia (arteriosclerosis, thrombosis)
-↓ ventilation, perfusion, diffusion, & O2 binding to Hgb -resp diseases, MI, hemorrhagic shock, poisons, toxins -cellular responses -↓ ATP→anaerobic metabolism - Na+ K+ pump failure→↑ Na+ & Ca++ & ↓ K+ in cell - cellular swelling (Na+ influx) -Reperfusion injury -enzyme conversion - ↑ATP consumption during ischemia → catabolites → ↑ ROS reperfusion → cell membrane damage, ATP loss, apoptosis -Rx: antioxidants, anti-inflammatories
|
|
|
Term
What happens during ischemia? |
|
Definition
- progessive loss of O2
- shift from aerobic to anaerobic
- buildup of lactic acid
- rapid ↓ in mitochondrial phosphorylation, due to lack of O2
- LOSS OF ATP
- Na+, K+ pump and Na+, Ca++ exchange failure
- influx of Na+ & Ca++, release of K+
- cellular swelling as H2O enters cell
- dilation of ER, detachment of Ribosomes, loss of protein synthesis
**at this point, process is reversible**
- vacuolation
- activation of multiple enzymes & lysosomes
- DNA degradation
- Cell death
|
|
|
Term
Cellular Injury Mech: ROS |
|
Definition
- Free radicals
-electrically unstable molecule(s) -disrupt chemical bonds of cell membranes (b/c free radical will bond with proteins, lipids, carbs) -destroy cell membrane & structure
- ROS
-low levels beneficial? -high levels → apoptosis, necrosis -lipid peroxidation (destruction of unsaturated fatty acids, also lipid-radical interactions yield peroxides), alterations of proteins causing fragmentation of polypeptide chains) & DNA alterations -inactivation of free radicals (antioxidants, enzymes) -all cells capable of making ROS, but effects of inflammatory & CV disease (e.g. HTN, ischemic heart disease) widespread
|
|
|
Term
Cellular Injury Mech: Hematomas |
|
Definition
- collection of blood in soft tissue v. enclosed space
- subdural: blook bt brain & surface dura
-venous blood, slow -fall, blow, sudden acceleration, deceleration
- epidural: blood bt dura & skull
-arterial blood, fast -skull fracture
|
|
|
Term
Manifestations of Cellular Injury |
|
Definition
- Cellular accumulations (infiltrations)
-water, lipids, carbs, glycogen, proteins, pigments, Ca++, urate -crowd organells, release metabolites
- excess endogenous production, ineffective catabolism, or exogenous exposure
- migration of phagocytes→tissue swelling
- reversible (liver cirrhosis) or irreversible (exogenous poisoning)
|
|
|
Term
Manifestations of Cellular Injury: Clinical |
|
Definition
- fever- endogenous pyrogens, acute inflammatory response
- ↑ HR- ↑ metabolism
- ↑WBC- infection
- pain- bradykinins, pressure
- ↑ enzymes (LDH, CK, AST, ALT, ALP, amylase)
|
|
|
Term
|
Definition
vacuolar or hydropic degeneration; happens during cellular swelling (in hypoxia, loss of ATP and metabolic function causes Na+ to build up in cell resulting in ↑ osmotic pressure resulting in increase in water inside the cell. vacuoles are created to isolate the water from the cytoplasm; basically oncosis is a degeneration of the cell by water) |
|
|
Term
Cell Death: Sequence of Events |
|
Definition
- ↓ ATP production
- Na+ - K+ pump (active transport) failure
- cellular swelling (NaCl influx into cells)
- ribosome detachment from ER
- ↓ protein synthesis
- intracellular Ca++ → mitochondrial swelling
- cytoplasmic vacuolation
- lysozome leakage of digestive enzymes
- autodigestion of intracellular structures (nucleus, nucleolus, halting DNA/RNA synthesis)
- plasma membrane lysis
|
|
|
Term
|
Definition
- sum of cellular changes after local cell death & process of cellular autodigestion
- widespread
- cell swelling
- rupture of cellular organisms
- inflammatory response
- causes: prolonged hypoxia, infection, cell membrane damge
|
|
|
Term
|
Definition
- definition: sum of cellular changes following cell death occuring primarily in the kidneys, heart & adrenal glands; commonly results from hypoxia
- etiology: protein denaturation of plasma proteins, which causes albumin to change from a gelatinous state to a firm, opaque state
- pathogenesis:
-severe ischemia -chemical injury (HgCl) -abnormalities in intracellular levels of Ca++
|
|
|
Term
|
Definition
- definition: refers to death of tissue
- etiology: hypoxic injury, commonly associated with arteriosclerosis, especially in the lower leg
- pathogenesis
-arterial blockage -subsequent bacterial invasion -Dry gangrene- result of coagulative necrosis -wet gangrene- develops when neutrophils invade the site; causes liquefactive necrosis -gas gangrene- caused by infection by Clostridium
|
|
|
Term
|
Definition
- definition: necroses which commonly results from injury to neuron and glial cells in the brain
- etiology: hydrolytic enzymes (hydrolases) from dead brain cells digest surrounding brain cells; liquified tissue is then walled off from healthy tissue, forming cysts
- pathogenesis:
-ischemic injury to neuron/glial cells -bacterial infection, causing release of neutrophil hydrolases; pus accumulation
|
|
|
Term
|
Definition
- commonly results from TB infection; is a combo of coagulative & liquefactive necrosis
- the dead cells disintegrate, but the debris isn't digested completely by hydrolases
- tissues resemble clumped cheese
- a granulomatous inflammatory wall encloses areas of causeous necrosis
|
|
|
Term
Cellular Death: Apoptosis |
|
Definition
- programmed cellular death (scattered, single cells)
- enzyme synthesis, protease-induced shrinkage, cell fragmentation, phagocytosis
- apoptosis (physiologic or pathologic)
-single cell, nuclear/cytoplasm shrinkage, quick & clean; no swelling or inflammation
- vs. necrosis (pathologic)
-tissue cells swell & lyse, slow & messy, inflammation of neighboring cells
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- osmotic forces (passive transport)
-primary control/regulation
- aquaporins (H2O channel proteins, provide permeability to H2O)
- starling hypothesis
-NET Filtration -movement of H2O from capillary to interstitial space *F favoring filtration-F opposing filtration *(cap hydrostatic + interstitial oncotic) - (plasma oncotic + interstitial hydrostatic)
|
|
|
Term
|
Definition
- mediated, needs energy
- Na+, K+, Ca++, amino acids moved by active transport w/carrier against concentration gradient
- Na+ K+ pump carrier protein
- Na+ K+ ATPase: enzyme splits ATP for energy
-proteins/organic substances cannot cross cell membrane (↑ ICF osmotic pressure, H2O diffuses into cell)
- 3 Na+ ions from ICF→ECF; 2 K+ ions from ECF→ICF (↓ ICF osmotic pressure & H2O diffusion)
- electrical gradient (membrance potential)
-nerve & muscle function, APs
|
|
|
Term
|
Definition
- forces favoring filtration (arterial end)
-cap hydrostatic P (BP) -interstitial oncotic P (H2O pulling)
- forces favoring reabsorption (venous end)
-plasma oncotic P (H2O pulling) -interstitial hydrostatic P
- capillary membrane damage
-movement of proteins to interstitial→edema
|
|
|
Term
|
Definition
- accumulation of fluid in interstitial space
- local or systemic: not available for perfusion/metabolism (3rd space)
-lymphodema, pitting edema, cerebral edema, pulmonary edema, ascites -weight gain, swelling, puffiness, impaired wound healing
- causes:
-↑ cap hydrostatic P (venous constriction, Na+ & H2O retention) -↓ plasma albumin (liver disease, protein malnutrition) -↑ cap permeability (inflammatory & immune cell injury causes) -lymph obstruction (infection, tumor, surgical removal)→ lymphedema
- Rx: elevation, compression, ↓ Na + intake, diuretics, underlying cause
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- ↑ glomerular filtration rate (GFR)
- renin-angiotensin-aldosterone (RAA)
-aldosterone secreted when - ↓ Na+ - ↑ K+ - ↓ blood volume
- natriuretic peptides (RAA antagosnists: ↓BP, ↑Na+ & H2O excretion)
-atrial natriuretic peptide (ANP - atria) -brain natriuretic peptide (BNP - ventricles) -urodilantin (kidneys)
|
|
|
Term
Na+, Cl-, H2O balance - alterations |
|
Definition
- infants, obese, & elderly - ↑ risk for imbalance
- isotonic alterations
-total body water change, proportional electrolyte & H2O change, no cellular shrinking or edema -hypovolemia→ ↓ atrial P → ↑ ADH secretion -isotonic volume depletion (hemorrhage, wound drainage, diaphoresis, intestinal loss) → ↓ weight, dry skin & mucous membranes), ↑ HR, ↓ U.O. -isotonic volume excess (IV, ↑ aldosterone secretion with renal Na+ & H2O retention, corticosteroids, renal failure)
|
|
|
Term
Hypertonic alterations: H2O defecit |
|
Definition
- intracellular dehydration →hypovolemia
-dehydration -pure H2O deficits -renal free H2O clearance -hyperglycemia
- manifestations
-tachycardia, ↓ BP, thirst, fever -↑ hematocrit & serum Na+
- Rx: slow D5W
|
|
|
Term
Hypertonic Alterations: Hypernatremia |
|
Definition
- serum sodium >147 mEq/L
- related to sodium gain or water loss
- water movement from the ICF to the ECF
-intracellular dehydration (cells shrink) -hypervolemia
- manifestations:
-convulsions, pulmonary edema, fever, tachycardia, confusion, coma
- Rx with D5W
|
|
|
Term
|
Definition
- major intracellular cation
- concentration maintained by Na+ K+ pump
- regulates intracellular electrical neutrality in relation to Na+ & H+
- essential for transmission and conduction of nerve impulses, normal cardiac rhythms, and skeletal and smooth muscle contraction
|
|
|
Term
|
Definition
- changes in pH & K+ balance
-H+ accumulates in ICF with acidosis -K+ shifts out to maintain cation balance across membrane
- aldosterone, insulin, and catecholamines influence serum potassium levels
|
|
|
Term
|
Definition
- Potassium level > 5.5 mEq/L
- Hyperkalemia is rare due to efficient renal excretion
- caused by shift of K+ (metabolic acidosis), ↓ renal excretion (renal failure), insulin deficiency, cell trauma (e.g. crush injuries), acidosis
- Rx: insulin (K+ & glucose from ECF→ICF)
- Mild
-hyperpolarized membrane→neuromuscular irritability -tingling of lups and fingers, restlessness, intestinal cramping, and diarrhea
- Severe
-cell unable to repolarize→muscle weakness, loss or muscle tone, flaccid paralysis, arrhythmia, peaked T wave, ↓ ST segment, wide QRS
- Rx: correct acid-base, Ca++ gluconate, glucose, NaHCO3, dialysis, insulin (K+ & glucose from ECF→ICF)
|
|
|
Term
|
Definition
- ↓s block of Na+ into cell
- ↑ neuromuscular excitability (partial depolarization)
- muscle cramps, tetany
- Chvostek's & Trousseau's signs
- < 8.5 mg/dL
- inadequate intestinal absorption, blood administration, ↓ PTH
|
|
|
Term
|
Definition
|
Term
|
Definition
|
|
Term
|
Definition
- Normal arterial blood pH
-7.35-7.45 -obtained by arterial blood gas (ABG) sampling
- Normal pCO2
-35-45
- Normal HCO3
-22-26
- Normal pO2
-80-100
- acidosis
-systemic ↑ in H+ concentration
- alkalosis
-systemic ↓ in H+ concentration
|
|
|
Term
|
Definition
- pH determines acid-base status
-PaCO2→respiratory component -HCO3-/BE → metabolic component
- acid-base imbalances:
-Metabolic Acidosis: ↓ HCO3- (↑ acid or ↓ base) -Metabolic Alkalosis: ↑ HCO3- (↓ acid or ↑ base) -Resp Acidosis: ↑ pCO2 (ventilatory depression) -Resp Alkalosis: ↓ pCO2 (alveolar hyperventilation)
|
|
|
Term
|
Definition
- Symptoms
-Weakness, N/V, warm/flushed skin, HA -hyperventilation or Kussmaul's breathing to ↓ PaCO2 (compensation) -dysrhythmia, hypotension, coma
- causes:
-lactic acid (hypoxia), ↑ ketones (fat metabolism in DM), salicylate poisoning, starvation/protein malnutrition, ↓ renal blood flow (↓ H+ excretion), ↑ urea (renal failure), ↓ HCO3- reabsorption (renal failure), chronic diarrhea
- Rx: Treat underlying cause, administer base
|
|
|
Term
|
Definition
- Symptoms
-confusion, ↑ reflexes, spasms, tetany, paresthesias, seizure, dysrhythmia & coma (altered cell depolarization)
- causes
-vomiting (CI- loss), N/G suction, diuretics, dehydration, ECF electrolyte alteration, ↓ HCO3- glomerular filtration, HCO3- containing antacids, hypochloremic (Cl leaves cell, H+ enters), hypokalemia (↑ renal H+ excretion)
- Rx
-replace Cl- or K+, NaCl for dehydration
|
|
|
Term
|
Definition
- Hypercapnea = alveolar hypoventilation
- Symptoms
-HA, restlessness, blurred vision, vasodilation, tremors, convulsions, coma
- causes
-resp depression, pulmonary disorders, airway obstruction, COPD, neuromuscular disorders
- Rx: maximize ventilation
|
|
|
Term
|
Definition
- Hypocapnea = alveolar hyperventilation
- symptoms
-dizziness, confusion, tingling, tachypnea, convulsions, coma
- causes
-hypoxemia, CHF, ↑ altitude, thyrotoxicosis, ASA intoxication, cirrhosis, sepsis, iatrogenic (mechanical ventilation)
- Rx: minimize ventilation as appropriate
|
|
|
Term
|
Definition
- (1st) epithelial barrier & (2nd) inflammation
- cellular
-macrophages -dendritic cells -NK lymphocytes
- complement system
- cytokines
-mediate host defense -inflammatory response -recruit T and B cells
|
|
|
Term
|
Definition
- antigen-specific response
- provides specificity & memory
- Cellular
-T lymphocytes -CD4 -CD8
- Humoral
-B lymphocytes -immunoglobins
- Cytokines
|
|
|
Term
|
Definition
o AKA polymorphonuclear (PMN cells or segmental neutrophils
o 1st responder-immediate phagocytosis
o Call for B/U (chemotaxis)
o Initiate vasodilation & capillary permeability
o Ingest bacteria, dead cells, & cellular debris
o Cells short-lived & incorporated into purulent exudate |
|
|
Term
|
Definition
o Primary helminthic (parasitic) defense
o Minor phagocytosis
o Regulate vascular mediators released from mast cells
§ Mast cells release ECF-A à attracts eosinophils to site of inflammation
§ Eosinophilic enzymes degrade vasoactive molecules (e.g. histaminase to degrade histamine) |
|
|
Term
|
Definition
- release histamine, bradykinin & serotonin
-↑ capillary permeability -↑ blood flow to injury site
- secrete heparin (anticoagulant) as check to coagulation cascade
- functional similarity to mast cells, but circulate in blood
- source of cytokine IL-4 (regulator of acquired immune response via B-cell differentiation)
|
|
|
Term
|
Definition
- circulate in blood
- arrive at scene after neutrophils (hrs-7days)
- in tissue, monos mature into macrophages
-ingest cell debris/bacteria
- macros produce cytokines (suppress further inflammation & initiate healing) & activate adaptive immune system
|
|
|
Term
|
Definition
- circulate as inactive until activated by specific molecules per genetic program
- B cell lymphocytes
-mature in bone marrow -Humoral immune system - circulate in blood → plasma cell mounts immune response
- T cell lymphocytes
-mature in thymus gland -cellular immune system -may release chemicals to activate humoral response -stimulate (pro) or inhibit (anti) inflammatory cytokines -destroy intracellular viruses/parasites where B cells don't go
|
|
|
Term
|
Definition
- produced in bone marrow, maturation unclear, circulates in blood
-present in blood and tissues
- Non-specific innate defense
-unlike T cytotoxic cells, do not require previous exposure to antigen
- recognize & destroy cells injured by viruses or cancer
|
|
|
Term
|
Definition
- cytoplasmic fragments in bone marrow
- adhere to vessel wall at injury site in aggregates or clumps
- release biochemical mediators (e.g. histamine, serotonin) to ↓ blood flow & bleeding - temporary vasoconstriction
- small injury - aggregation allows healing
- circulation time ~ 10 days
- ↓ platelet count → multiple small hemorrhages throughout body
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- physical & mechanical
-skin -linings of GI, GU, & respiratory tracks -sloughing of cells (turnover), coughing/sneezing, flushing, vomiting, urination, mucus & cilia
- Biochemical
-saliva, tears, earwax, sweat, mucus, & sebum -antimicrobial peptides (active cells of immunity) -cathelicidins, defensins, & collectins (lung)
|
|
|
Term
Biochemical Barriers
(part of 1st line of defense) |
|
Definition
- normal bacterial flora
-aid digestion & absorption -produce Vitamin K & chemicals to inhibit pathogenic colonization -altered by prolonged antibiotic Rx -Clostridium difficile & Candida albicans overgrowth - ↓ vaginal protection from Lactobacillus
|
|
|
Term
|
Definition
- diverse causes; nonspecific (independent of stimulus/insult or past exposure)
- act at site of cellular injury to:
1. confine damage 2. kill microorganisms 3. remove debris -can be painful & harm healthy tissue
- vasodilation (redness & heat), ↑ vascular permeability & leakage (edema), WBC adherence to inner vessel walls & migration through vessel walls to injury site (diapedesis)
- cardinal "signs" of inflammation
-redness, heat, swelling, pain (local) -fever, leukocytosis, plasma protein synthesis (systemic)
|
|
|
Term
|
Definition
|
|
Term
Acute Inflammatory Response |
|
Definition
|
|
Term
Chronic Inflammatory Response |
|
Definition
|
|
Term
|
Definition
- Protein systems
-complement system (potent defense) -clotting system -kinin system
- all contain inactive enzymes (proenzymes)
-sequentially activated -produce potent substrates that are regulated to avoid damage to healthy tissue
|
|
|
Term
Complement
(Plasma Protein System) |
|
Definition
- direct pathogen destruction
- activates or collaborates with other inflammatory response components
- pathways
-classical (Antigen-antibody complex, protein C1, substrate conversions) -Lectin (antibody-independent) -alternative (B/U with endotoxin & yeast)
- Functions: anaphylatoxis (mast cell degranulation), leukocyte chemotaxis, opsonization (Tag! you're it- tag pathogenic micro orgs for phagocytosis), & cell lysis
|
|
|
Term
Clotting
(Plasma Protein System) |
|
Definition
- forms fibrinous meshwork at site of injury
-prevents spread of infection -keeps micro orgs & foreign bodies at site of inflammation for phagocytic removal -forms clot that stops bleeding -provides framework for repair & healing
- main substance is fibrin (end product of clotting cascade)
- intrinsic & extrinsic pathways
-converge at factor X → common pathway to fibrin clot
|
|
|
Term
Kinin
(Plasma Protein System) |
|
Definition
- activates inflammatory cells
- bradykinin - primary
-dilates vessels (vasodilation) -with prostaglandins, stimulates nerve endings (pain) - ↑s vascular permeability & leukocyte chemotaxis
- rapidly degraded by plasma & tissue enzymes
|
|
|
Term
Plasma Protein Systems
(Clotting & Kinin) |
|
Definition
|
Term
cellular mediators of inflammation |
|
Definition
- cellular components (blood and/or tissues)
-granulocytes, monocytes, lymphocytes, & platelets -secrete & respond to biochemical mediators
- immune cell surface receptors
-pattern recognition receptors (PRRs) -host-environment interface (e.g. skin, GI tract) -toll-like, complement, scavenger, etc. receptors -on surface of immune cells; others are secreted -bridge bt innate & acquired immunity via cytokine induction (↑ lymphocyte response to pathogen) -pathogen-associated molecular patterns (PAMPs)
|
|
|
Term
Mediators of Inflammation |
|
Definition
- vasodilation: histamine, NO, prostaglandins
- vascular permeability: bradykinin, histamine, leukotrienes, platelet-activating factor (PAF)
- pain: bradykinin, prostaglandins (E series)
- systemic effects:
-fever: IL-1, IL-6, TNF-α, prostaglandins -leukocytosis: granulocytes (G-CSF), leukocytes (IL-1, TNF-α), mast cells/eosinophils (IL-4, IL-5), monocytes (M-CSF), NK (IL-2) -acute phase reactants: C-RP, IL-1, IL-6, IL-8, TNF-α
- limit inflammation:
-ECF-A (attracts eosinophils) -histaminase (destroy histamine) -IL-10 (inhibits cytokine production) -TGF-β (inhibits macrophage proliferation)
- immune response: IL-1, IL-2, IL-4, IL-5, IL-6, IFN-γ
- repair & healing: angiogenic factors (VEGF→stimulate endothelial & fibroblast growth), IFN-γ (interferon that activates macrophages), TGF-β (stimulates fibroblast growth)
- phagocytosis: C5, IL-1, leukotrienes, & many more
|
|
|
Term
|
Definition
- cellular bags of granules locaated in connective tissue close to blood vessels
-skin, GI & resp tracts -contain biochemical mediators: histamine, chemotactic factors (e.g. ECF-A), cytokines (TNF-α, IL-4)
- activation
-physical injury, chemical agents, immunologic processes, & toll-like receptors -chemical release of potent chemicals -degranulation (immediate response) & synthesis of lipid-derived inflammatory mediators (long-term response)
|
|
|
Term
|
Definition
- histamine
-vasoactive amine- ↑ blood flow by temporary, rapid constriction of large blood vessels & dilation of postcapillary venules - ↑ vascular permeability by retraction of endothelial cells lining capillaries -receptors: -H1 receptor (PRO-inflam→bronchial smooth muscle cells) -H2 receptor (ANTI-inflam→gastric mucosea parietal cells, induces secretion of gastric acid)
|
|
|
Term
(events before) phagocytosis |
|
Definition
- production of adhesion molecules (selectins & integrins)
- margination(pavementing)-leukocyte adherence to endothelial cells
- diapedesis-emigration of cells through endothelial junctions
- chemotaxis- tissue invasion; cell movement along a cellular gradient
- recognition & attachment
- phagocytosis
|
|
|
Term
|
Definition
- opsonization (tag, you're it!)- recognition of target & adherence of the phagocyte to it
- engulfment (endocytosis)- ingestion
- fusion with lysosomal granules within the phagocyte (phagolysosome)
- destruction of the target
- neutrophils (early), macros & lymphs (later)
|
|
|
Term
Inflammation: Local Manifestations |
|
Definition
- local inflam with ALL cellular injury
- results from vascular changes & corresponding leakage of circulating components into tissue
-heat (vasodilation & ↑ blood flow at site of injury) -redness (vasodilation & ↑ blood flow at site of injury) -swelling (accumulation of exudate[fluids & cells]) -pain (pressure from exudate accumulation, prostaglandins & bradykinin)
|
|
|
Term
Inflammation: Systemic Manifestations |
|
Definition
- fever
-caused by exogenous (pathogen-produced) & endogenous (e.g. IL-1 released from neutrophils & macros) pyrogens
- leukocytosis
-↑ # of circulating leukocytes -"left shift" in ratio of immature (bands) to mature neutrophils
- ↑ plasma protein synthesis
-acute-phase reactants (pro- or anit-inflam) -C-reactive protein, fibrinogen, ceruplasmin, complement components, etc.
|
|
|
Term
|
Definition
- inflammatory response
-rapid -nonspecific -short-lived
|
|
|
Term
|
Definition
- slower
- specific
- long-lived, memory
- antigens
-"non-self" substances (bacteria, virus, fungi, parasite, pollen, toxin, vaccine, transfusion, transplantation)
- antibodies (immunoglobins)
- lymphocytes
- phases
-clonal diversity -clonal selection
|
|
|
Term
|
Definition
- B cell differentiation→circulating antibody binds to antigens via plasma cell→direct (inactivate microorganism) or indirect (activates inflammatory mediators that destroy pathogen)
- protection against bacteria & viruses
|
|
|
Term
|
Definition
- T-cell differentiation (T regulatory, cytotoxic T, or memory T)→direct (inactivates microorganism) or indirect (activates inflammatory mediators that destroy pathogen) or avoid attacking self (T regulatory)
- protection against viruses & cancer
|
|
|
Term
|
Definition
- antibodies or T cells produced after either natural exposure to antigen or immunization
- long-lived
|
|
|
Term
|
Definition
- preformed antibodies or T lymphocytes are transferred from donor to recipient (e.g. placenta)
- short-lived
|
|
|
Term
inappropriate immune response |
|
Definition
- allergy-exaggerated immune response against environmental antigens (e.g. hay fever)
- autoimmunity- immune response directed against "self" (e.g. systemic lupus erythematosis [SLE])
- alloimmunity- immune response against beneficial foreign tissue (e.g. transfusion, transplant rejection)
- immune deficiency- response insufficient to protect host (e.g. AIDS)
|
|
|
Term
|
Definition
- required for a successful immune response
- clusters of differentiation (CD)
-originally used to describe proteins found on surface of lymphocytes -now a labeling system to ID family of proteins on many cells
|
|
|
Term
|
Definition
- also called immunoglobulins
- produced by plasma cells
- classes of antibody
-IgG, IgA, IgM, IgE, & IgD -characterized by antigenic, structural, & functional differences
|
|
|
Term
Immunoglobulins G (IgG) & A (IgA) |
|
Definition
- IgG
-most abundant class (80-85%) -transported across placenta
- IgA
-IgA1 predominantly in blood -IgA2 predominantly in body secretions (e.g. saliva, breast milk, resp secretions)
|
|
|
Term
|
Definition
- Least concentrated of immunoglobulin classes in circulation
- mediator of many common allergic rxns
- defender against parasites
-initiates inflam rxn to attract eosinophils
|
|
|
Term
Antigen Processing & Presentation |
|
Definition
- Antigens require processing & presentation by antigen-presenting cells (APCs)
-dendritic cells, macrophages, B lymphocytes
- for processing & presentation:
-antigen must be appropriate type -lymphocytes must be prepared to recognize presented antigen -antigen must be presented appropriately
|
|
|
Term
Primary Response (priming the pump) |
|
Definition
- mechanism of vaccination
- latent period after novel antigen exposure
-B cell differentiation occurring
- after 5-7 days, IgM antibody detected
- IgG response ≤ IgM response follows
|
|
|
Term
|
Definition
- mechanism of vaccination
- more rapid with larger antibody amounts
- presence of memory cells, differentiation not required
- IgM produced similarly to primary response, but IgG produced in greater amounts
|
|
|
Term
|
Definition
- cytotoxic T lymphocytes
-destroy virus or cancer cells
- NK cells
-complement cytotoxic T cells
- Regulatory T cells
-suppress proliferation steps of antigen recognition
|
|
|
Term
|
Definition
- subsets
-Th1 cells provide help in developing cell-mediated immunity -Th2 cells provide help in developing humoral immunity -differences based on cytokine production
|
|
|
Term
|
Definition
- altered immunologic response to antigen→disease/damage to host
-allergy-deleterious effects of hypersensitivity to environmental (exogenous) antigens -autoimmunity- disturbance in immunologic tolerance of self-antigens -alloimmunity-immune response to tissues of another individual
- mechanisms of types overlap
- Histamine release
-H1 (smooth muscle contraction→bronchospasm) & H2 (↑ gastric acid secretion, ↓ histamine release from mast cells & basophils) receptors -antihistamine
- sensitixation against antigen needed
-primary & secondary immune responses
- immediate or delayed hypersensitivity
-anaphylaxis (bee sting, penicillin allergy) most rapid & severe, immediate -systemic (itching, erythema, headache, vomiting, abdominal cramps, diarrhea, dyspnea, bronchospasm, laryngeal edema, vascular collapse -Rx: Epinephrine IV or subQ
|
|
|
Term
|
Definition
- IgE mediated
-mast cells
- against environmental antigens (allergens)
- examples: hay fever, food allergies
- itching, urticaria, conjunctivitis, rhinitis, GI cramps or malabsorption, ↓ BP, bronchospasm
- desensitization (blocking antibodies [e.g. IgG] complete with IgE)
|
|
|
Term
|
Definition
- tissue-specific rxn
- antibody (IgG or IgM) binds to specific tissue antigen on cell surface & activates complement cascade→cell membrane damage & lysis; phagocytosis (macrophages); other mechanisms
- e.g. autoimmune hemolytic anemia, ABO-mismatched blood, Graves disease, SLE
- manifestations tissue-dependent
|
|
|
Term
Hypersensitivity Type III |
|
Definition
- immune complex-mediated (antigen-antibody complexes formed in blood and deposited in vessel wall or extravascular tissue)
-IgG or IgM -dynamic & heterogeneous complement activation→neutrophils & lysosomal enzymes→tissue damage
- e.g. raynaud phenomenon, autoimmune hemolytic anemia, ABO-mismatched transfusion, SLE, serum sickness
|
|
|
Term
Systemic Lupus Erythematosus (SLE) |
|
Definition
- caused by deposition of immune complexes in various organs→inflammatory response→tissue damage
- heterogeneous presentation
- involves type II & III
- symptoms vary pt to pt
-fatigue, arthralgias, dermatologic complaints, nephropathy, CNS, cardiac, respiratory, GI
|
|
|
Term
|
Definition
- cell-mediated
-mediated by T lymphocytes, not antibody
- cytotoxic T lymphocytes (direct destruction) or Th1 cells (phagocyte recruitment→ROS & cell lysis)
-e.g. acute graft rejection, TB skin test (positive in photo), poison ivy, metal allergies
|
|
|
Term
Bacterial Virulence & Infectivity |
|
Definition
- bacteria must have iron to multiply
-siderophores (iron receptors)
- presence of polysaccharide capsules
- suppression of complement activation
- bacterial proliferation rates can surpass protective response
- Toxin production:
- exotoxins
-enzymes released during growth causing specific responses -immunogenic -antitoxin production
- endotoxins
-lipopolysaccharides contained in cell walls of G- organisms -pyrogenic effects
|
|
|
|
|